-The United Nations A sustained rise in prices for raw natural resources and basic agricultural goods is defying long-standing patterns and appears to be hurting poor nations through rising food and fuel costs more than it is helping them through higher revenues for their commodities exports. That was one of the findings of the Commodities and Development Report 2012, a study launched at the 13th session of the UN Conference on Trade...
More »SEARCH RESULT
Total Matching Records found : 2709
Public goods as the way to welfare-Pulapre Balakrishnan
There is evidence to show that growth is slowly becoming inclusive. But for the quality of life to improve, incomes must be complemented by infrastructure. For close to at least five years now inclusive growth has had a central place in the official discourse on the economy. The UPA II has itself worn its self-proclaimed success in delivering an inclusive growth as a badge of its effectiveness, not to mention its...
More »Glaring gender bias ails heart health-Kounteya Sinha
Women in India face discrimination even when it comes to their heart health. Three separate studies - one of them from India and the other two from China and West Asia - presented at the World Congress of Cardiology in Dubai on Friday said that women don't receive the same treatment as men for heart disease across the world. They said that women with acute coronary syndrome (ACS) receive inferior or less...
More »Shamnad Basheer, Intellectual Property Law Professor at NUJS interviewed by V Venkatesan
PROFESSOR Shamnad Basheer joined the National University of Juridical Sciences (NUJS), Kolkata, in November 2008 as the first Ministry of Human Resource Development Chaired Professor in Intellectual Property Law. Before this, he was Frank H. Marks Visiting Associate Professor of Intellectual Property Law at the George Washington University law school and a research associate at the Oxford Intellectual Property Research Centre (OIPRC). He is the founder of several initiatives, including...
More »A welcome first -TK Rajalakshmi
Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...
More »
